PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1731891
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1731891
Global Sphygmomanometers Market to Reach US$6.2 Billion by 2030
The global market for Sphygmomanometers estimated at US$3.8 Billion in the year 2024, is expected to reach US$6.2 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Mercury Sphygmomanometer, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in the Aneroid Sphygmomanometer segment is estimated at 5.8% CAGR over the analysis period.
The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 13.4% CAGR
The Sphygmomanometers market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 13.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.1% and 8.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.
Global Sphygmomanometers Market - Key Trends & Drivers Summarized
Why Are Sphygmomanometers Still Vital in the Era of Digital Health Monitoring?
Sphygmomanometers remain the cornerstone of cardiovascular assessment, used globally to measure blood pressure in clinical, ambulatory, and home settings. Despite the rise of wearable health tech, these instruments-whether manual (aneroid and mercury-based) or digital (automatic electronic devices)-continue to serve as the gold standard for hypertension screening and chronic disease management. As cardiovascular diseases remain the leading cause of death worldwide, accurate blood pressure measurement remains a foundational healthcare need.
The aging population, increasing obesity rates, and lifestyle-induced hypertension are amplifying the demand for frequent and reliable blood pressure monitoring. Sphygmomanometers are used not only in hospitals and physician offices but also by patients at home to manage chronic conditions. In low-resource settings, manual devices are still preferred due to durability and independence from electricity. At the same time, high-income countries are transitioning toward fully automated digital monitors integrated with patient data systems.
How Are Technologies Enhancing Accuracy and Connectivity in Modern Devices?
Digital sphygmomanometers now incorporate oscillometric sensors, automatic cuff inflation, and real-time display of systolic and diastolic values with high precision. Bluetooth and Wi-Fi connectivity features allow users to sync readings with mobile apps and electronic medical records (EMRs), enabling remote monitoring by healthcare professionals. AI algorithms are also being developed to detect irregular heart rhythms or signal variability, offering additional diagnostic insight.
Innovations in cuff design, including wide-range and cuffless technologies, are improving ease of use and reducing operator dependency. Some advanced monitors now use photoplethysmography (PPG) and tonometry for continuous, non-invasive blood pressure monitoring. Integration with wearable fitness trackers and telemedicine platforms is also enhancing preventive care and chronic disease management strategies across both urban and rural populations.
Which Healthcare Segments and Regions Are Leading Adoption?
Primary care and cardiology departments continue to be the largest users of sphygmomanometers, followed by emergency medicine, internal medicine, and nephrology units. Home-use digital monitors are witnessing the fastest growth, driven by patient self-monitoring and home-based care models. Pharmacies, elder care facilities, and wellness centers are also expanding their deployment of automated blood pressure kiosks.
North America and Europe lead the market in terms of innovation, regulatory approvals, and digital device penetration. Asia-Pacific is rapidly catching up due to the high prevalence of hypertension and rising healthcare access in China, India, and Southeast Asia. Government health campaigns, public-private screening initiatives, and rural telehealth expansion are fueling demand. Latin America and Africa are key growth markets for low-cost, durable, and clinically validated manual devices.
The Growth in the Sphygmomanometers Market Is Driven by Several Factors…
It is driven by the global burden of hypertension, increasing demand for home-based monitoring solutions, and technological advancements in wireless and connected diagnostics. The integration of Bluetooth-enabled monitors with cloud-based health management systems supports remote patient monitoring and personalized treatment pathways. Rising adoption of digital health platforms and EMR-compatible devices in hospitals and outpatient clinics is accelerating demand for connected sphygmomanometers.
Government screening programs, public health guidelines advocating regular blood pressure checks, and the shift toward preventive care models are also boosting device uptake. In emerging markets, the availability of low-cost, mercury-free manual alternatives is facilitating widespread access in primary care and rural health settings. The convergence of device miniaturization, improved sensor technology, and increased patient engagement is set to sustain strong growth in the global sphygmomanometers market.
SCOPE OF STUDY:
The report analyzes the Sphygmomanometers market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Type (Mercury Sphygmomanometer, Aneroid Sphygmomanometer, Digital Sphygmomanometer); Operation (Manual, Semi-Automatic, Automatic); Modality (Wall Mounted, Portable, Other Modalities); End-User (Hospitals & Clinics, Homecare Settings, Ambulatory Surgery Centers, Other End-Users)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 41 Featured) -
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.
We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.
As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.
To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!
APRIL 2025: NEGOTIATION PHASE
Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.
JULY 2025 FINAL TARIFF RESET
Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.
Reciprocal and Bilateral Trade & Tariff Impact Analyses:
USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.
Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.
COMPLIMENTARY PREVIEW
Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.